HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

2-propylquinoline

structure in first source

Also Known As:

2-n-propylquinoline; 2nPQ cpd

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinolines: 146
      - 2-propylquinoline: 4

Experts

1.	Balaraman, Kaluvu: 1 article (12/2015)
2.	Bories, Christian: 1 article (12/2015)
3.	Cojean, Sandrine: 1 article (12/2015)
4.	Figadère, Bruno: 1 article (12/2015)
5.	Kesavan, Ventikasamy: 1 article (12/2015)
6.	Loiseau, Philippe M: 1 article (12/2015)
7.	Moussa, Fathi: 1 article (12/2015)
8.	Pomel, Sébastien: 1 article (12/2015)
9.	Vacus, Joël: 1 article (12/2015)
10.	Vieira, Nashira Campos: 1 article (12/2015)

Related Diseases

1.	Leishmaniasis 12/01/2015 - "2-n-propylquinoline (2-n-PQ) had shown interesting in vivo antileishmanial activities after administration by oral route on leishmaniasis animal models. " 09/04/1998 - "A high-performance liquid chromatographic method was developed for the specific determination of 2-n-propylquinoline, a new anti-leishmaniasis drug, in plasma and liver homogenates of mice. "
2.	Chagas Disease (American Trypanosomiasis) 11/01/2001 - "These results are encouraging for continuing the investigation of other analogues of 2-n-propylquinoline in experimental chronic Chagas' disease." 11/01/2001 - "Experimental treatment of chronic Trypanosoma cruzi infection in mice with 2-n-propylquinoline."
3.	Visceral Leishmaniasis (Kala Azar) 03/01/1994 - "We now report the antileishmanial activity of four 2-substituted quinoline alkaloids, namely chimanine D or 2-(1',2'-trans-epoxypropyl) quinoline (I), 2-n-propylquinoline (II), 2-styrylquinoline (III) and 2-(2'-hydroxypropyl) quinoline (IV), for experimental treatment of visceral leishmaniasis in infected BALB/c mice. "
4.	Infections 11/01/2001 - "The reference drug and 2-n-propylquinoline were administered 60 days post-infection for 30 days at 25 mg/mL. At 35 days post-treatment, the serological tests (ELISA) of the 2-n- propylquinoline-treated mice were significantly different from the controls (p = 0.01) and the benznidazole-treated mice (p = 0.03), while this was not the case at 85 days post-treatment. "

Related Drugs and Biologics

1.	Alkaloids
2.	quinoline
3.	benzonidazole (benznidazole)